Keaveny, T.M.
Clarke, B.L.
Cosman, F.
Orwoll, E.S.
Siris, E.S.
Khosla, S.
Bouxsein, M.L.
Article History
Received: 27 November 2019
Accepted: 9 March 2020
First Online: 26 April 2020
Compliance with ethical standards
:
: Keaveny: Founder and consulting Chief Scientific Officer, O.N. Diagnostics; consulting for Amgen, Agnovos Healthcare, Bone Health Technologies; equity in O.N. Diagnostics.Clarke: Advisory board and grant support from Shire/Takeda, Inc.; Data Monitoring Board for Bristol-Myers-Squibb.Cosman: Consulting, advisory board, speaking fees, and/or grant support from Amgen, Eli Lilly, Radius, Merck, and RPharm US.Orwoll: Consulting for Bayer and Amgen. Research support from Mereo BioPharma.Siris: none.Khosla: none.Bouxsein: Grant support from Radius and Amgen; consulting fees from Agnovos Healthcare